Kymera Therapeutics Inc. (KYMR)
Market Closed
3 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XKLS $
73. 21
+1.92
+2.6932%
$
6.72B Market Cap
- P/E Ratio
- Div Yield
846,880 Volume
-2.54 Eps
$ 71.29
Previous Close Investors:
Want to track KYMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
Kymera (KYMR) announces expansion plans of ongoing mid-stage studies on KT-474 (SAR444656) by partner Sanofi.
Zacks | 1 year ago
